Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2020 · 10-Q
Revenue—
Net Income-$1.84M-$1.84MN/M vs Q2 2019 EPS Diluted-$0.45-$0.45N/M vs Q2 2019 Operating Income-$2,352,000N/M Operating Cash Flowderived-$1,409,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,421,000N/M ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end